fda changes semaglutide just got FDA-approved for kidney disease. This everything., January 2025. The approved semaglutide (Ozempic/Wegovy) for a new indication: reducing kidney disease progression in is ro semaglutide fda approved
Description
I'm so glad I found her! -E
The neurodegeneration program lost its two largest tests
Some patients start with a compounded option for cost reasons and later transition to a brand-name medication
Cardiovascular risk factors may worsen, particularly in patients who regain significant weight
Not doing so may lead to unwanted side effects, loss of muscle mass, and poor markers of health other than weight
doi: 10.3390/ijms25073812, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar] 85.Meissner WG, Remy P, Giordana C, Maltete D, Derkinderen P, Houeto JL, et al
